Skip to content

Envoy Medical COCH Deferred Tax Assets, Gross

Deferred Tax Assets, Gross at other companies

Banner Corporation logo
Banner CorporationBANR
$127.77M-14.3%
Corebridge Financial logo
Corebridge FinancialCRBG
$7.82B-13.6%
Bank of America logo
Bank of AmericaBAC
$24.18B-5.9%
Silvercrest Asset Management Group logo
Silvercrest Asset Management GroupSAMG
$1.71M-59.6%
Center Bancorp logo
Center BancorpCNOB
$137.68M+193%
MSCI logo
MSCIMSCI
$191.15M+1.9%

Other financials

Income statement

See full
Revenue$39.0K-15.2%
Gross profit-$274.0K-52.2%
Operating income-$6.0M-16.7%
Net income-$4.4M+12.9%
EPS (diluted)-$0.08+72.4%

Balance sheet

See full
Cash & equivalents$25.3M+376%
Total debt$919.0K-2.8%
Total equity$10.2M+142%
Total assets$29.8M+187%

Cash flow

See full
Operating cash flow-$6.1M-62.7%
CapEx$172.0K
Free cash flow-$5.9M-28.5%

Valuation

See full
Market cap$61M+83.5%
P/S260.7×+111×

Profitability

See full
Gross margin-310.7%+31.6pp
Operating margin-9,881.2%+805pp
Net margin-9,875.6%+771pp
FCF margin-7,626.6%-652pp

Returns & leverage

See full
Return on equity328.7%
Debt / equity0.1×
Current ratio2.3×+1.2×

Where this comes from

Reported directly by Envoy Medical in its filing.

Tagged under the XBRL concept us-gaap:DeferredTaxAssetsGross.

The official record: Envoy Medical’s 10-K, filed March 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Envoy Medical's deferred tax assets, gross.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Envoy Medical's deferred tax assets, gross?
Envoy Medical (COCH) reported deferred tax assets, gross of $50.97M in Q4 2025.
What is the long-term trend for Envoy Medical's deferred tax assets, gross?
Over 3 years (2022 to 2025), Envoy Medical's deferred tax assets, gross has grown at a 4.7% compound annual growth rate (CAGR), from $44.42M to $50.97M.